Human Apolipoprotein A-I (Apo A1) ELISA Kit (with Control)

$453.00

Catalog Number: EA5201-7

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Competitive ELISA

Entrez Gene

335

Components

Biotinylated Human Apolipoprotein A-I Protein, Chromogen Substrate (1x), Human Apolipoprotein A-I Microplate, Human Apolipoprotein A-I Standard, MIX Diluent Concentrate (10x), Positive Control, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

2 hours

Sensitivity

0.12 µg/ml

Range

0.156 – 10 ug/ml

Samples Type

Plasma, Serum

Associated Disease

Cancer, Cardiovascular, Heart Disease, Metabolism

Species

Human

UniProt

P02647

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications citing Assaypro: Human Apolipoprotein A-I (Apo A1) ELISA Kit ... (59 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Role of DJ-1 and Apo A1 as biomarkers in Parkinson's disease: an observational case-control study

Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and...

Phytosterols and omega 3 supplementation exert novel regulatory effects on metabolic and inflammatory pathways: a proteomic study

Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome

High performance lipoprotein profiling for cardiovascular risk assessment

Intervenciones nutricionales en la prevenci�n cardiovascular y efectos de los factores de riesgo en el tejido adiposo

Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function

Nutritional interventions in cardiovascular prevention and effects of risk factors on adipose tissue

Leptin and Tumor necrosis factor alpha in breast

Serum Syndecan-1 and Apolipoprotein A1 in patients with chronic HCV infection

Diagnostic value of apolipoprotein A1 in neonatal sepsis

Role of DJ-1 and Apo A1 as biomarkers in Parkinson?s disease: an observational case-control study

Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria

Assessment of the relationship between markers of inflammation, adipokines and lipid metabolism parameters in overweight and obese individuals.

Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity

A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients

Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers

Glycoproteome of human apolipoprotein AI: N-and O-glycosylated forms are increased in patients with acute myocardial infarction

The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease

Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients

The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents

Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach

Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD

High Performance Lipoprotein Profiling for Cardiovascular Risk Assessment

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]

Identification of haptoglobin and apolipoprotein AI as biomarkers for high altitude pulmonary edema

High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease

A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function

Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus

Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study

Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients

ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma

The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols.

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA [S]

Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas

Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers

CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.

Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome

Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction

Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children

Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels

Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics

Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD

The Effects of Rope Training on Lymphocyte ABCA1 Expression, Plasma ApoA-I and HDL-c in Boy Adolescents

Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach *

Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis

Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.

Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level

Plasma profiles in active systemic juvenile idiopathic arthritis: biomarkers and biological implications

Loading data...